Promega GloMax® Luminometer's Multi-Mode Capability Enhances Lab Performance
MADISON, WISCONSIN (February 7, 2008)
Promega Corporation announces the release of the GloMax®-Multi Detection System. The new GloMax gives scientists even more capability and flexibility with the leading luminescence detection instrument. Now with multi-mode capability, GloMax also reads fluorescence and absorbance detection in 96-well plates. The modular detection design allows a scientist to expand into these new applications as needed. This is particularly applicable for cancer research, cell biology and drug screening.
With a simple touch-screen interface, GloMax operates as an independent work station. There's no need for a computer to operate the instrument. Scientists can run experiments on their schedule and then transfer data to a computer at any time via a USB port.
By offering optimized performance and pre-installed protocols, this GloMax instrument makes an ideal platform for the multiplexing of assays, such as with the new MultiTox-Glo Multiplex Cytotoxicity assay. An injection system is also available for use with the Dual-Luciferase Reporter (DLR™) Assay System. The GloMax-Multi Detection System will be demonstrated at:
AACR Annual Meeting
San Diego, CA
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com
These pages contain communications on Promega product releases and corporate activities. For additional new product information, see the new products page or the specific product or application area.
For more information about a press release or about Promega in general, contact Promega Corporate Affairs at 1-608-274-4330 or via our contact page.